Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test

Summary: The sudden loss of smell is among the earliest and most prevalent symptoms of COVID-19 when measured with a clinical psychophysical test. Research has shown the potential impact of frequent screening for olfactory dysfunction, but existing tests are expensive and time consuming. We develope...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, Javier Pizarro-Berdichevsky, Andrés Finkelstein-Kulka, Sandra Solari, Nicolás Salas, Pedro Bahamondes, Martín Ugarte, Pablo Barceló, Marcelo Arenas, Eduardo Agosin
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/a6d164bd43b94d57bcd4c1cc39e9e393
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a6d164bd43b94d57bcd4c1cc39e9e393
record_format dspace
spelling oai:doaj.org-article:a6d164bd43b94d57bcd4c1cc39e9e3932021-11-24T04:33:07ZScreening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test2589-004210.1016/j.isci.2021.103419https://doaj.org/article/a6d164bd43b94d57bcd4c1cc39e9e3932021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589004221013900https://doaj.org/toc/2589-0042Summary: The sudden loss of smell is among the earliest and most prevalent symptoms of COVID-19 when measured with a clinical psychophysical test. Research has shown the potential impact of frequent screening for olfactory dysfunction, but existing tests are expensive and time consuming. We developed a low-cost ($0.50/test) rapid psychophysical olfactory test (KOR) for frequent testing and a model-based COVID-19 screening framework using a Bayes Network symptoms model. We trained and validated the model on two samples: suspected COVID-19 cases in five healthcare centers (n = 926; 33% prevalence, 309 RT-PCR confirmed) and healthy miners (n = 1,365; 1.1% prevalence, 15 RT-PCR confirmed). The model predicted COVID-19 status with 76% and 96% accuracy in the healthcare and miners samples, respectively (healthcare: AUC = 0.79 [0.75–0.82], sensitivity: 59%, specificity: 87%; miners: AUC = 0.71 [0.63–0.79], sensitivity: 40%, specificity: 97%, at 0.50 infection probability threshold). Our results highlight the potential for low-cost, frequent, accessible, routine COVID-19 testing to support society's reopening.Susana EyheramendyPedro A. SaaEduardo A. UndurragaCarlos ValenciaCarolina LópezLuis MéndezJavier Pizarro-BerdichevskyAndrés Finkelstein-KulkaSandra SolariNicolás SalasPedro BahamondesMartín UgartePablo BarcelóMarcelo ArenasEduardo AgosinElsevierarticleDiagnostic technique in health technologyDiagnosticsHealth technologyMathematical biosciencesScienceQENiScience, Vol 24, Iss 12, Pp 103419- (2021)
institution DOAJ
collection DOAJ
language EN
topic Diagnostic technique in health technology
Diagnostics
Health technology
Mathematical biosciences
Science
Q
spellingShingle Diagnostic technique in health technology
Diagnostics
Health technology
Mathematical biosciences
Science
Q
Susana Eyheramendy
Pedro A. Saa
Eduardo A. Undurraga
Carlos Valencia
Carolina López
Luis Méndez
Javier Pizarro-Berdichevsky
Andrés Finkelstein-Kulka
Sandra Solari
Nicolás Salas
Pedro Bahamondes
Martín Ugarte
Pablo Barceló
Marcelo Arenas
Eduardo Agosin
Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
description Summary: The sudden loss of smell is among the earliest and most prevalent symptoms of COVID-19 when measured with a clinical psychophysical test. Research has shown the potential impact of frequent screening for olfactory dysfunction, but existing tests are expensive and time consuming. We developed a low-cost ($0.50/test) rapid psychophysical olfactory test (KOR) for frequent testing and a model-based COVID-19 screening framework using a Bayes Network symptoms model. We trained and validated the model on two samples: suspected COVID-19 cases in five healthcare centers (n = 926; 33% prevalence, 309 RT-PCR confirmed) and healthy miners (n = 1,365; 1.1% prevalence, 15 RT-PCR confirmed). The model predicted COVID-19 status with 76% and 96% accuracy in the healthcare and miners samples, respectively (healthcare: AUC = 0.79 [0.75–0.82], sensitivity: 59%, specificity: 87%; miners: AUC = 0.71 [0.63–0.79], sensitivity: 40%, specificity: 97%, at 0.50 infection probability threshold). Our results highlight the potential for low-cost, frequent, accessible, routine COVID-19 testing to support society's reopening.
format article
author Susana Eyheramendy
Pedro A. Saa
Eduardo A. Undurraga
Carlos Valencia
Carolina López
Luis Méndez
Javier Pizarro-Berdichevsky
Andrés Finkelstein-Kulka
Sandra Solari
Nicolás Salas
Pedro Bahamondes
Martín Ugarte
Pablo Barceló
Marcelo Arenas
Eduardo Agosin
author_facet Susana Eyheramendy
Pedro A. Saa
Eduardo A. Undurraga
Carlos Valencia
Carolina López
Luis Méndez
Javier Pizarro-Berdichevsky
Andrés Finkelstein-Kulka
Sandra Solari
Nicolás Salas
Pedro Bahamondes
Martín Ugarte
Pablo Barceló
Marcelo Arenas
Eduardo Agosin
author_sort Susana Eyheramendy
title Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
title_short Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
title_full Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
title_fullStr Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
title_full_unstemmed Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
title_sort screening of covid-19 cases through a bayesian network symptoms model and psychophysical olfactory test
publisher Elsevier
publishDate 2021
url https://doaj.org/article/a6d164bd43b94d57bcd4c1cc39e9e393
work_keys_str_mv AT susanaeyheramendy screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT pedroasaa screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT eduardoaundurraga screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT carlosvalencia screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT carolinalopez screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT luismendez screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT javierpizarroberdichevsky screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT andresfinkelsteinkulka screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT sandrasolari screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT nicolassalas screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT pedrobahamondes screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT martinugarte screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT pablobarcelo screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT marceloarenas screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
AT eduardoagosin screeningofcovid19casesthroughabayesiannetworksymptomsmodelandpsychophysicalolfactorytest
_version_ 1718415995734851584